Question 1

What specific benefits could PIR provide compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus clinical trial (NCT07187479). Contact the study team or your healthcare provider for specific answers.

Question 2

Are there any risks or side effects associated with PIR that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus clinical trial (NCT07187479). Contact the study team or your healthcare provider for specific answers.

Question 3

How often would I need to come in for visits if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus clinical trial (NCT07187479). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience a low blood sugar during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus clinical trial (NCT07187479). Contact the study team or your healthcare provider for specific answers.

Question 5

Will my current medications for diabetes and CKD be affected if I join this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus clinical trial (NCT07187479). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus clinical trial (NCT07187479). Contact the study team or your healthcare provider for specific answers.

What this study is about